The Pradaxa multi-district litigation (MDL) met in early February for a status conference to discuss recent progress made in the discovery and deposition processes. According to Seth A. Katz, one…
Read More
Published August 30, 2012 on LawsuitInformation.org In early August, a Minnesota man filed a lawsuit against the manufacturer of Levaquin, Ortho McNeil Janssen Pharmaceuticals, a manufacturing unit of Johnson &…
Read More
The Yaz and Yasmin multidistrict litigation (MDL) convened for a status conference on September 4, 2013 in the U.S. District Court for the Southern District of Illinois. The court met…
Read More
A settlement agreement has been reached between Bayer and plaintiffs who filed a Yaz and Yasmin lawsuit specifically citing gallbladder complications. The settlement agreement between the plaintiffs and Bayer, the…
Read More
According to a Reuters report published on March 4, Bayer allocated $1.5 billion last year as a legal fund for Yaz and Yasmin lawsuits. In anticipation of future settlements of…
Read More
Transvaginal mesh is used to treat patients with pelvic organ prolapse (POP) and stress urinary incontinence (SUI). As a national law firm representing individuals who believe their injuries (stem) from…
Read More
A Colorado woman's transvaginal mesh lawsuit was set to go to trial in New Jersey when C. R. Bard, the defendant in the case, decided to settle the case. Filed…
Read More
Transvaginal mesh lawsuits have been consolidated into five multi-district litigation (MDL) cases in the U.S. District Court for the Southern District of West Virginia. U.S. District Judge Joseph R. Goodwin…
Read More
Endo announced a day after the U.S. Food and Administration (FDA) proposed an order to classify transvaginal mesh as a high-risk device that they had reached a settlement agreement of…
Read More
The federal court hearing the Ethicon MDL in West Virginia filed a pretrial order earlier this month that provides important discovery and deposition deadlines for two upcoming bellwether trials. Pretrial…
Read More